Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Oct-24 5:39 PM View:  | Halozyme Therapeutics, Inc. (HALO) | 09-Oct-24 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 1% 676.74K to 686.74K | |
| 09-Oct-24 5:39 PM View: | Halozyme Therapeutics, Inc. (HALO) | 09-Oct-24 | Planned Option Sale | 10,000 | $52.58 | $525,783.00 | (1%) 686.74K to 676.74K | |
| 09-Oct-24 5:39 PM View: | Halozyme Therapeutics, Inc. (HALO) | 08-Oct-24 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 1% 676.74K to 686.74K | |
| 09-Oct-24 5:39 PM View: | Halozyme Therapeutics, Inc. (HALO) | 08-Oct-24 | Planned Option Sale | 10,000 | $54.00 | $539,961.00 | (1%) 686.74K to 676.74K | |
| 26-Sep-24 6:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 26-Sep-24 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 1% 676.74K to 686.74K | |
| 26-Sep-24 6:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 26-Sep-24 | Planned Option Sale | 10,000 | $56.10 | $560,970.00 | (1%) 686.74K to 676.74K | |
| 26-Sep-24 6:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 25-Sep-24 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 1% 676.74K to 686.74K | |
| 26-Sep-24 6:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 25-Sep-24 | Planned Option Sale | 10,000 | $56.34 | $563,370.00 | (1%) 686.74K to 676.74K | |
| 26-Sep-24 6:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 24-Sep-24 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 1% 676.74K to 686.74K | |
| 26-Sep-24 6:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 24-Sep-24 | Planned Option Sale | 10,000 | $58.21 | $582,100.00 | (1%) 686.74K to 676.74K | |
| 12-Sep-24 5:56 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Sep-24 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 1% 676.74K to 686.74K | |
| 12-Sep-24 5:56 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Sep-24 | Planned Option Sale | 10,000 | $59.20 | $592,030.00 | (1%) 686.74K to 676.74K | |
| 12-Sep-24 5:56 PM View: | Halozyme Therapeutics, Inc. (HALO) | 11-Sep-24 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 1% 676.74K to 686.74K | |
| 12-Sep-24 5:56 PM View: | Halozyme Therapeutics, Inc. (HALO) | 11-Sep-24 | Planned Option Sale | 10,000 | $59.09 | $590,870.00 | (1%) 686.74K to 676.74K | |
| 12-Sep-24 5:56 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Sep-24 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 1% 676.74K to 686.74K | |
| 12-Sep-24 5:56 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Sep-24 | Planned Option Sale | 10,000 | $59.09 | $590,890.00 | (1%) 686.74K to 676.74K | |
| 15-Aug-24 4:59 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Aug-24 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 1% 676.74K to 686.74K | |
| 15-Aug-24 4:59 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Aug-24 | Planned Option Sale | 10,000 | $57.95 | $579,490.00 | (1%) 686.74K to 676.74K | |
| 15-Aug-24 4:59 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Aug-24 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 1% 676.74K to 686.74K | |
| 15-Aug-24 4:59 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Aug-24 | Planned Option Sale | 10,000 | $57.25 | $572,471.00 | (1%) 686.74K to 676.74K | |
| 15-Aug-24 4:59 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Aug-24 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 1% 676.74K to 686.74K | |
| 15-Aug-24 4:59 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Aug-24 | Planned Option Sale | 10,000 | $56.25 | $562,490.00 | (1%) 686.74K to 676.74K | |
| 20-Feb-24 6:49 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Feb-24 | Payment of Exercise | 20,362 | $36.10 | $735,068.00 | (3%) 697.11K to 676.74K | |
| 20-Feb-24 6:49 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Feb-24 | Option Exercise | 37,884 | -- | -- | 6% 659.22K to 697.11K | |
| 16-Feb-24 5:39 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-24 | Grant | 32,781 | -- | -- | 5% 638.0K to 670.78K | |
| 16-Feb-24 5:39 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-24 | Payment of Exercise | 24,655 | $35.91 | $885,361.00 | (4%) 683.88K to 659.22K | |
| 16-Feb-24 5:39 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-24 | Option Exercise | 13,092 | -- | -- | 2% 670.78K to 683.88K | |
| 13-Feb-24 4:12 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-24 | Payment of Exercise | 16,943 | $35.49 | $601,307.00 | (3%) 654.95K to 638.0K | |
| 13-Feb-24 4:12 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-24 | Option Exercise | 31,281 | -- | -- | 5% 623.67K to 654.95K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Aug-23 | Planned Option Sale | 10,000 | $42.82 | $428,170.00 | (2%) 633.67K to 623.67K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 30-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 30-Aug-23 | Planned Option Sale | 10,000 | $42.85 | $428,540.00 | (2%) 633.67K to 623.67K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 29-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 29-Aug-23 | Planned Option Sale | 10,000 | $42.40 | $424,020.00 | (2%) 633.67K to 623.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 17-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 17-Aug-23 | Planned Option Sale | 10,000 | $43.18 | $431,820.00 | (2%) 633.67K to 623.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Aug-23 | Planned Option Sale | 10,000 | $43.53 | $435,320.00 | (2%) 633.67K to 623.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Aug-23 | Planned Option Sale | 10,000 | $43.77 | $437,680.00 | (2%) 633.67K to 623.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 27-Jul-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 27-Jul-23 | Planned Option Sale | 10,000 | $43.79 | $437,900.00 | (2%) 633.67K to 623.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 26-Jul-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 26-Jul-23 | Planned Option Sale | 10,000 | $42.69 | $426,890.00 | (2%) 633.67K to 623.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 25-Jul-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 25-Jul-23 | Planned Option Sale | 10,000 | $42.80 | $427,960.00 | (2%) 633.67K to 623.67K | |
| 09-Mar-23 5:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 09-Mar-23 | Option Exercise | 10,000 | $14.66 | $146,600.00 | 2% 623.67K to 633.67K | |
| 09-Mar-23 5:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 09-Mar-23 | Planned Option Sale | 10,000 | $42.73 | $427,270.00 | (2%) 633.67K to 623.67K | |
| 09-Mar-23 5:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 08-Mar-23 | Option Exercise | 10,000 | $14.66 | $146,600.00 | 2% 623.67K to 633.67K |